(3R,4R)-1-Nitroso Tofacitinib
It is an impurity present in Tofacitinib, Tofacitinib is an inhibitor of Janus kinases is a group of intracellular enzymes involved in signaling pathways that affect hematopoiesis and immune cell function, prevent the body from responding to cytokine signals. by that prevents the phosphorylation and activation of STATs, the JAK-STAT signaling pathway is the transcription of cells involved in hematopoiesis and immune cell function. which works by inhibiting the JAK-STAT pathway to decrease the inflammatory response, there is evidence to suggest that it may achieve efficacy via other pathways as well.
Additional information on (3R | 4R)-1-Nitroso Tofacitinib
VE009926
N/A
C13H18N6O
274.33 g/mol
Tofacitinib
N-methyl-N-((3R, 4R)-4-methyl-1-nitrosopiperidin-3-yl)-5H-pyrrolo[2, 3-d]pyrimidin-4-amine
N/A
J. Kucharz, E., Stajszczyk, M., Kotulska-Kucharz, A., Batko, B., Brzosko, M., Jeka, S., … Wiland, P. (2018). Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology. Reumatologia/Rheumatology, 56(4), 203–211. https://doi.org/10.5114/reum.2018.77971
In-stock
